Jordan Amos, enterprise account executive, UK public sector specialist at LogicMonitor, discusses why health trusts need to prioritise the right technology to succeed with their digital transformation projects.
Could 2024 be the year that UK manufacturers finally embrace robotics? After trailing behind our international counterparts for years, FANUC UK discusses how the UK is now starting to catch up when it comes to the installation of industrial robotics.
Ryan Phelan, partner and registered patent attorney at Marshall, Gerstein & Borun, examines the intellectual property challenges involving artificial intelligence in the medical technology sector.
Has all investment in digital health been positive? Shameem C Hameed, founder and CEO of blueBriX, provides insight into industry advances, why he believes over investment is killing digital health and how the sector will evolve in 2024 and beyond.
John Pugh, healthcare and life sciences lead at Slalom, outlines the importance – and looks at some specific aspects of – strategy when deploying AI in the sector.
Chris Whitehouse, a political consultant and expert on medical technology policy and regulation at Whitehouse Communications, looks at the background of what could be the next team of health and social care ministers.
Vertical integration is a strategy where a company expands its business operations into different stages along its production path, effectively controlling the key steps from design to marketing a final product.
Alan Smith, negotiations specialist and director of Scotwork International, shares seven lessons derived from his experience working with clients in the medical device industry.
Medical device manufacturers are increasingly turning to specialist plastics formulated to resist harsh chemicals and survive environmental end use conditions such as sterilisation. Kevin Brownsill shares guidance on bonding specialist plastics.
